We’re Serious About Science
Esteem Therapeutics believes emerging digital therapeutic technologies are having a profound impact on personal health and behavioral health. We see a future where a technology-empowered, multi-disciplinary approach will improve clinical outcomes for the many who are struggling with chronic disease. We are building that future.
The Esteem Therapeutics science team has over 30 years of collective experience developing award-winning, evidence-based, peer-reviewed and scientifically-validated products and technologies. Esteem’s first commercial products will address childhood and adult ADHD.
We value openness and collaboration. We’ve partnered leading universities and teaching hospitals and will continue our strong history of conducting clinical trials, publishing case-studies, and peer-reviewed data.
If you’re interested in collaborating with us, please contact Dr. Thomas Pedigo, Ed.D, ABMP, MSCP, BCN.
Parent ADHD Primer: The Current State of ADHD
As one of the most commonly diagnosed childhood disorders, Attention Deficit Hyperactivity Disorder (ADHD) is described as a complicated neuro-developmental psychiatric disorder where individuals are affected behaviorally, socially, and academically both at home, at school, and across many social situations. The primary treatment of these children, aged 4-18, is psychotropic (mind-altering) medication.
Esteem Estimates that up to 13M Children Could be Affected by ADHD
According to a recent population-based study,15.5% of school children enrolled in grades one to five have ADHD. The study combined the results of rating scales completed by teachers and telephone interviews of parents for 7,847 children (Rowland et al. 2015).
American Academy of Pediatrics Takes the Lead
The American Academy of Pediatrics (AAP) mission on mental health is to provide a base from which primary care providers can develop alliances with families, work to prevent mental health conditions and identify them early,
and collaborate with mental health clinicians.
In 2011, the National Institute of Health and the AAP published updated guidelines to help physicians better address concerns about ADHD
and to improve standards of care.
American Academy of Pediatrics (2000). Clinical Practice Guideline: Diagnosis and Evaluation of the Child With Attention-Deficit/Hyperactivity Disorder. Pediatrics 105, 1158-1170.
Pediatricians Left Carrying the Load
Even with the AAP objective of developing an alliance model, primary care physicians have been charged with taming the growing ADHD industry and with slowing or reducing the use of powerful medications when treating childhood behavioral and educational issues.
However, even with guidelines some physicians have had difficulty making the necessary time in office to meet all the requirements for comprehensive and chronic care. Additionally, many offices find limited cooperation of the insurance industry and a lack of tools and community resources needed to address the guidelines effectively.
In 2011, the AAP recognized the difficulty and complexity of the solution:
“The diagnosis and management of ADHD in children and youth has been particularly challenging for primary care clinicians because of the limited payment provided for what requires more time than most of the other conditions they typically address.
The procedures recommended in this guideline necessitate spending more time with patients and families, developing a system of contacts with school and other personnel, and providing continuous, coordinated care, all of which is time demanding.
In addition, relegating mental health conditions exclusively to mental health clinicians also is not a viable solution for many clinicians, because in many areas access to mental health clinicians to whom they can refer patients is limited.
Access in many areas is also limited to psychologists when further assessment of cognitive issues is required and not available through the education system because of restrictions from third-party payers in paying for the evaluations on the basis of them being educational and not health related.”
Pediatricians are feeling mounting pressure across every part of their practice In 2016, leading managed care entities informed pediatricians they could no longer refer children for psychological assessment placing more responsibility and accountability and liability on pediatricians.